super - Story: SUP23 Page: 9 of 10 Issue: 6/23/97 Dom Int...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
AMGEN 67.8% 108.1% 29.0% ORACLE 53.5% 59.7% 17.9% WORLDCOM 53.0% 50.7% 23.0% MICROSOFT 51.0% 46.8% 34.2% CONSECO 47.3% 55.6% 28.1% NIKE 46.9% 21.3% 14.5% CHAMPION ENTERPRISES 46.7% 49.6% 4.6% INTEL 43.8% 33.1% 22.1% HARLEY-DAVIDSON 43.3% 22.0% 9.1% MICRON TECHNOLOGY 41.8% 65.1% 13.0% PACIFICARE HEALTH SYSTEMS 41.3% 40.3% 2.1% APPLIED MATERIALS 40.6% 42.4% 13.5% HOME DEPOT 40.2% 36.4% 7.1% COMPAQ COMPUTER 36.9% 43.0% 12.8% IOMEGA 36.6% 42.4% 2.0% UNITED HEALTHCARE 36.0% 52.1% 7.4% SUNAMERICA 35.0% 60.9% 26.7% While many of its competitors in the biotech industry let the disease lead them to the science, Amgen stays ahead by taking the opposite approach. It develops hit drugs by identifying areas of promising research that may lead to breakthrough products. Oracle took the sleepy data-management software business by storm, crushed its competitors, and developed new applications that allow corporations to exploit their data as never before. WorldCom saw there was more than one way to be a telephone company. By offering customers not only long distance but also local and Internet services, it broke out of the pack and became a powerhouse in the U.S. telecommunications industry. Now that Microsoft has established itself as king of the PC software world, it’s off to the
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.
Ask a homework question - tutors are online